These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 2116682
1. Immunological characterization of factor VIII inhibitors by a sensitive micro-ELISA method. Sánchez-Cuenca JM, Carmona E, Villanueva MJ, Aznar JA. Thromb Res; 1990 Mar 15; 57(6):897-908. PubMed ID: 2116682 [Abstract] [Full Text] [Related]
2. Detection of two different anti-factor VIII/von Willebrand factor antibodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG class. Carmona E, Aznar JA, Jorquera JI, Villanueva MJ, Sánchez-Cuenca JM. Thromb Res; 1991 Jul 01; 63(1):73-84. PubMed ID: 1948824 [Abstract] [Full Text] [Related]
3. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity. Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F. Acta Haematol; 2005 Jul 01; 114(2):84-90. PubMed ID: 16103630 [Abstract] [Full Text] [Related]
4. Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assay. Mondorf W, Ehrenforth S, Vigh Z, Last J, Tippmann G, Kreuz W, Scharrer I. Vox Sang; 1994 Jul 01; 66(1):8-13. PubMed ID: 8146988 [Abstract] [Full Text] [Related]
5. [Factor VIII epitopes recognized by inhibitors in hemophiliacs]. Hayashi T, Niiya K, Sakuragawa N, Ichihara K, Yamazaki T, Watanabe A. Rinsho Ketsueki; 1991 Sep 01; 32(9):945-50. PubMed ID: 1719257 [Abstract] [Full Text] [Related]
7. Autoantibody to von Willebrand factor in systemic lupus erythematosus. Soff GA, Green D. J Lab Clin Med; 1993 Mar 01; 121(3):424-30. PubMed ID: 8445290 [Abstract] [Full Text] [Related]
8. Inhibitors to factor IX contain all IgG subclasses except IgG3. Orstavik KH. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Mar 01; 117(4):545-8. PubMed ID: 1714858 [Abstract] [Full Text] [Related]
9. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay. Pezeshkpoor B, Berkemeier AC, Herbst K, Albert T, Müller J, Oldenburg J. J Thromb Haemost; 2024 Jun 01; 22(6):1591-1604. PubMed ID: 38453023 [Abstract] [Full Text] [Related]
10. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies. Sahud M, Zhukov O, Mo K, Popov J, Dlott J. Haemophilia; 2012 Sep 01; 18(5):777-81. PubMed ID: 22458845 [Abstract] [Full Text] [Related]
13. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients. Montalvão SA, Tucunduva AC, Siqueira LH, Sambo AL, Medina SS, Ozelo MC. Haemophilia; 2015 Sep 01; 21(5):686-92. PubMed ID: 25708525 [Abstract] [Full Text] [Related]
14. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]. Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A. Rinsho Ketsueki; 1996 Nov 01; 37(11):1303-8. PubMed ID: 8960666 [Abstract] [Full Text] [Related]
15. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Loizou S, Cofiner C, Weetman AP, Walport MJ. Clin Exp Immunol; 1992 Dec 01; 90(3):434-9. PubMed ID: 1458679 [Abstract] [Full Text] [Related]
16. Immunochemical characterization of factor VIII inhibitors. Hoyer LW, Gawryl MS, de la Fuente B. Prog Clin Biol Res; 1984 Dec 01; 150():73-85. PubMed ID: 6431443 [Abstract] [Full Text] [Related]
17. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. Hashemi S, Smith CD, Izaguirre CA. J Lab Clin Med; 1987 Apr 01; 109(4):434-40. PubMed ID: 3546564 [Abstract] [Full Text] [Related]
18. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors. Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B. Haematologica; 2005 Sep 01; 90(9):1288-90. PubMed ID: 16154861 [Abstract] [Full Text] [Related]
19. Inhibitor to factor VIII in mild haemophilia. Kesteven PJ, Holland LJ, Lawrie AS, Savidge GF. Thromb Haemost; 1984 Aug 31; 52(1):50-2. PubMed ID: 6437010 [Abstract] [Full Text] [Related]